{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T23:58:51Z","timestamp":1770681531609,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Early Human Development"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.earlhumdev.2024.106051","type":"journal-article","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T01:51:58Z","timestamp":1716256318000},"page":"106051","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Neurobehavioral outcomes of infants exposed to buprenorphine-naloxone compared with naltrexone during pregnancy"],"prefix":"10.1016","volume":"194","author":[{"given":"Saaz","family":"Mantri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An-Chiao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelley","family":"Saia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hira","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Amgott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Bressler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha M.","family":"Werler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ginny","family":"Carter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hendree E.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisha M.","family":"Wachman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.earlhumdev.2024.106051_bb0005","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jama.2020.24991","article-title":"Neonatal abstinence syndrome and maternal opioid-related diagnoses in the US, 2010-2017","volume":"325","author":"Hirai","year":"2021","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.earlhumdev.2024.106051_bb0010","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1176\/appi.ps.202000075","article-title":"SAMHSA: creating a system of care that meets the needs of people with mental and substance use disorders","volume":"71","author":"McCance-Katz","year":"2020","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.earlhumdev.2024.106051_bb0015","author":"SAMSHA"},{"issue":"1","key":"10.1016\/j.earlhumdev.2024.106051_bb0020","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/pathophysiology30010004","article-title":"Safety and efficacy of buprenorphine-naloxone in pregnancy: a systematic review of the literature","volume":"30","author":"Ordean","year":"2023","journal-title":"Pathophysiology"},{"issue":"3","key":"10.1016\/j.earlhumdev.2024.106051_bb0025","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s13669-016-0168-9","article-title":"Caring for pregnant women with opioid use disorder in the USA: expanding and improving treatment","volume":"5","author":"Saia","year":"2016","journal-title":"Curr. Obstet. Gynecol. Rep."},{"issue":"6","key":"10.1016\/j.earlhumdev.2024.106051_bb0030","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000001004","article-title":"Buprenorphine-naloxone versus buprenorphine for treatment of opioid use disorder in pregnancy","volume":"16","author":"Perry","year":"2022","journal-title":"J. Addict. Med."},{"issue":"17","key":"10.1016\/j.earlhumdev.2024.106051_bb0035","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.2023.19761","article-title":"Pharmacotherapy for alcohol use disorder: a systematic review and meta-analysis","volume":"330","author":"McPheeters","year":"2023","journal-title":"JAMA"},{"issue":"10118","key":"10.1016\/j.earlhumdev.2024.106051_bb0040","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(17)32812-X","article-title":"Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial","volume":"391","author":"Lee","year":"2018","journal-title":"Lancet"},{"issue":"9776","key":"10.1016\/j.earlhumdev.2024.106051_bb0045","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S0140-6736(11)60358-9","article-title":"Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial","volume":"377","author":"Krupitsky","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.earlhumdev.2024.106051_bb0050","series-title":"StatPearls [Internet]","article-title":"Naltrexone","author":"Singh","year":"2023"},{"issue":"12","key":"10.1016\/j.earlhumdev.2024.106051_bb0055","article-title":"Opioid antagonists for alcohol dependence","author":"R\u00f6sner","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"issue":"8","key":"10.1016\/j.earlhumdev.2024.106051_bb0060","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/add.14946","article-title":"Acceptability and efficacy of naltrexone for criminal justice-involved individuals with opioid use disorder: a systematic review and meta-analysis","volume":"115","author":"Bahji","year":"2020","journal-title":"Addiction"},{"issue":"9","key":"10.1016\/j.earlhumdev.2024.106051_bb0065","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.clinthera.2019.07.003","article-title":"Naltrexone treatment for pregnant women with opioid use disorder compared with matched buprenorphine control subjects","volume":"41","author":"Wachman","year":"2019","journal-title":"Clin. Ther."},{"issue":"11","key":"10.1016\/j.earlhumdev.2024.106051_bb0070","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s40265-017-0762-9","article-title":"A retrospective cohort study of obstetric outcomes in opioid-dependent women treated with implant naltrexone, oral methadone or sublingual buprenorphine, and non-dependent controls","volume":"77","author":"Kelty","year":"2017","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.earlhumdev.2024.106051_bb0075","doi-asserted-by":"crossref","first-page":"83.e1","DOI":"10.1016\/j.ajog.2019.07.037","article-title":"Use of naltrexone in treating opioid use disorder in pregnancy","volume":"222","author":"Towers","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"7","key":"10.1016\/j.earlhumdev.2024.106051_bb0080","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/phar.1958","article-title":"Methadone, buprenorphine, and naltrexone for the treatment of opioid use disorder in pregnant women","volume":"37","author":"Tran","year":"2017","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.earlhumdev.2024.106051_bb0085","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.drugalcdep.2017.11.030","article-title":"Prenatal exposure to methadone or buprenorphine: early childhood developmental outcomes","volume":"185","author":"Kaltenbach","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.earlhumdev.2024.106051_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2019.12.018","article-title":"Neurodevelopmental outcomes of neonates randomized to morphine or methadone for treatment of neonatal abstinence syndrome","author":"Czynski","year":"2020","journal-title":"J. Pediatr."},{"issue":"7","key":"10.1016\/j.earlhumdev.2024.106051_bb0095","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.7025","article-title":"Cognitive and motor outcomes of children with prenatal opioid exposure: a systematic review and meta-analysis","volume":"2","author":"Yeoh","year":"2019","journal-title":"JAMA Netw. Open"},{"issue":"2","key":"10.1016\/j.earlhumdev.2024.106051_bb0100","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-0514","article-title":"Cognitive and behavioral impact on children exposed to opioids during pregnancy","volume":"144","author":"Larson","year":"2019","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.earlhumdev.2024.106051_bb0105","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/s41372-018-0109-8","article-title":"Quality improvement initiative to improve inpatient outcomes for neonatal abstinence syndrome","volume":"38","author":"Wachman","year":"2018","journal-title":"J. Perinatol."},{"issue":"8","key":"10.1016\/j.earlhumdev.2024.106051_bb0110","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1542\/hpeds.2018-0165","article-title":"Standard fixed-schedule methadone taper versus symptom-triggered methadone approach for treatment of neonatal opioid withdrawal syndrome","volume":"9","author":"Wachman","year":"2019","journal-title":"Hosp. Pediatr."},{"issue":"8","key":"10.1016\/j.earlhumdev.2024.106051_bb0115","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1542\/hpeds.2018-0238","article-title":"Reduction in length of stay and morphine use for NAS with the \u201ceat, sleep, console\u201d method","volume":"9","author":"Blount","year":"2019","journal-title":"Hosp. Pediatr."},{"issue":"3","key":"10.1016\/j.earlhumdev.2024.106051_bb0120","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/jcap.12042","article-title":"Grandchild of the NBAS: the NICU network neurobehavioral scale (NNNS): a review of the research using the NNNS","volume":"26","author":"Tronick","year":"2013","journal-title":"J. Child Adolesc. Psychiatr. Nurs."},{"issue":"1","key":"10.1016\/j.earlhumdev.2024.106051_bb0125","first-page":"5","article-title":"Ages and Stages Questionnaire: a global screening scale","volume":"74","author":"Singh","year":"2017","journal-title":"Bol. Med. Hosp. Infant. Mex."},{"issue":"4","key":"10.1016\/j.earlhumdev.2024.106051_bb0130","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1001\/jamapediatrics.2019.6000","article-title":"Comparative accuracy of developmental screening questionnaires","volume":"174","author":"Sheldrick","year":"2020","journal-title":"JAMA Pediatr."},{"key":"10.1016\/j.earlhumdev.2024.106051_bb0135","doi-asserted-by":"crossref","DOI":"10.7326\/M23-2430","article-title":"Responding to reviewers and editors about statistical significance testing","author":"Savitz","year":"2024","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.earlhumdev.2024.106051_bb0140","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.earlhumdev.2017.11.009","article-title":"Prenatal buprenorphine exposure and neonatal neurobehavioral functioning","volume":"117","author":"Velez","year":"2018","journal-title":"Early Hum. Dev."},{"issue":"6","key":"10.1016\/j.earlhumdev.2024.106051_bb0145","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/pr.2018.25","article-title":"NICU network neurobehavioral scale: 1-month normative data and variation from birth to 1 month","volume":"83","author":"Provenzi","year":"2018","journal-title":"Pediatr. Res."},{"issue":"4","key":"10.1016\/j.earlhumdev.2024.106051_bb0150","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jpeds.2013.04.033","article-title":"Prenatal substance exposure: neurobiologic organization at 1 month","volume":"163","author":"Conradt","year":"2013","journal-title":"J. Pediatr."},{"issue":"13","key":"10.1016\/j.earlhumdev.2024.106051_bb0155","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.3109\/10826084.2010.484474","article-title":"Infant neurobehavior following prenatal exposure to methadone or buprenorphine: results from the neonatal intensive care unit network neurobehavioral scale","volume":"45","author":"Jones","year":"2010","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.earlhumdev.2024.106051_bb0160","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jpeds.2021.12.057","article-title":"Effects of pharmacologic treatment for neonatal abstinence syndrome on DNA methylation and neurobehavior: a prospective cohort study","volume":"243","author":"Camerota","year":"2022","journal-title":"J. Pediatr."},{"issue":"10","key":"10.1016\/j.earlhumdev.2024.106051_bb0165","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1001\/jamapediatrics.2022.3079","article-title":"Utility of the ages and stages questionnaire to identify developmental delay in children aged 12 to 60 months: a systematic review and meta-analysis","volume":"176","author":"Muthusamy","year":"2022","journal-title":"JAMA Pediatr."},{"issue":"5","key":"10.1016\/j.earlhumdev.2024.106051_bb0170","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/cch.12704","article-title":"Use of ages and stages QuestionnairesTM (ASQ) in a Navajo population: comparison with the U.S. normative dataset","volume":"45","author":"Nozadi","year":"2019","journal-title":"Child Care Health Dev."},{"key":"10.1016\/j.earlhumdev.2024.106051_bb0175","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000001225","article-title":"National provider survey: use of naltrexone for pregnant individuals with substance use disorders","author":"Deflorimonte","year":"2023","journal-title":"J. Addict. Med."}],"container-title":["Early Human Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378378224001208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378378224001208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T07:56:13Z","timestamp":1718956573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378378224001208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":35,"alternative-id":["S0378378224001208"],"URL":"https:\/\/doi.org\/10.1016\/j.earlhumdev.2024.106051","relation":{},"ISSN":["0378-3782"],"issn-type":[{"value":"0378-3782","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurobehavioral outcomes of infants exposed to buprenorphine-naloxone compared with naltrexone during pregnancy","name":"articletitle","label":"Article Title"},{"value":"Early Human Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.earlhumdev.2024.106051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106051"}}